Showing results (2361-2370 of 2,695) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|May 21, 2019
Predictors of mortality in patients with yellow fever: an observational cohort studyEsper G Kallas, Luiz Gonzaga F A B D'Elia Zanella, Carlos Henrique V Moreira, et al.The Lancet. Infectious Diseases|May 14, 2019
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trialRobert W Frenck, John Ervin, Laurence Chu, et al.The Lancet. Infectious Diseases|September 30, 2017
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trialJohn H Beigel, Yajing Bao, Joy Beeler, et al.The Lancet. Infectious Diseases|December 8, 2018
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countriesYingfen Hsia, Mike Sharland, Charlotte Jackson, et al.The Lancet. Infectious Diseases|March 28, 2018
Tuberculosis: advances and challenges in development of new diagnostics and biomarkersGerhard Walzl, Ruth McNerney, Nelita du Plessis, et al.The Lancet. Infectious Diseases|November 21, 2017
Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trialSomphou Sayasone, Jennifer Keiser, Isabel Meister, et al.The Lancet. Infectious Diseases|January 12, 2020
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation studyFiona V Cresswell, Lillian Tugume, Nathan C Bahr, et al.The Lancet. Infectious Diseases|January 12, 2020
Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy studyJoseph Donovan, Do Dang Anh Thu, Nguyen Hoan Phu, et al.The Lancet. Infectious Diseases|February 2, 2020
Re-examining causes of surgical site infections following elective surgery in the era of asepsisJohn C Alverdy, Neil Hyman, Jack GilbertThe Lancet. Infectious Diseases|February 5, 2020
The status of tuberculosis vaccine developmentLewis K Schrager, Johan Vekemens, Nick Drager, et al.Pageof 270